Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00CSA
|
|||
| Former ID |
DIB005085
|
|||
| Drug Name |
LFF-269
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Phase 2 | [1] | |
| Company |
Novartis pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02047656) To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.